Atopic Dermatitis – Treatment Response EVALuation and UsEr Satisfaction with Tralokinumab in Standard Clinical Practice (ADValue)

Study identification

• EU PAS number:
  EUPAS1000000872
• Study ID:
  1000000872
• Official title and acronym:
  Atopic Dermatitis – Treatment Response EVALuation and UsEr Satisfaction with Tralokinumab in Standard Clinical Practice (ADValue)
• DARWIN EU® study:
  No
• Study countries:
  Germany
• Study description:
  No information provided.
• Study status:
  Planned

Research institutions and networks

Institutions

Universitätsklinikum des Saarlandes Klinik f. Dermatologie, Venerologie und Allergologie

Study timelines

Date when funding contract was signed

Actual:28/07/2025

Study start date

Planned:16/12/2025

Date of final study report

Planned:31/03/2030

Sources of funding

Pharmaceutical company and other private sector 

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

NIS-TRALO-2412